secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291671
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics receives Nasdaq bid price deficiency notice; has until June 3, 2024 to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on Dec 4, 2023 for failing minimum bid price of $1.00 for 30 consecutive trading days.
- Has 180 calendar days, until June 3, 2024, to regain compliance by closing bid >=$1.00 for 10 consecutive days.
- If not compliant by June 3, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- No immediate effect on listing; company intends to monitor and consider options to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523291671/0001193125-23-291671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523291671/d565852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer